Avsar.

Healthcare · Biotechnology

Advanced Enzyme Technologies Ltd (ADVENZYMES)

₹263.55

Mkt cap
₹2,951 Cr
P/E ratio
18.70
P/B
1.81
Div yield
2.03%
ROE
10.20%
ROCE
14.00%
EPS (TTM)
₹14.09
Book value
₹146
52W range
247–419
Sector
Healthcare

Price history

Previous close

Advanced Enzyme Technologies Limited is engaged in the business of manufacturing and sales of enzymes. [1]

NSE ADVENZYMESBSE 540025
Health check
Mixed
ValuationCheap
ProfitabilityAverage
GrowthModerate
TechnicalsBearish
52-week range
−37.10% from high
₹264
₹247+6.79% from low₹419
Current
₹263.55
Prev close
₹264.15
Day
−0.23%
Price performance
1D
−1.57%
1W
+4.69%
1M
−7.85%
3M
−15.09%
6M
−23.02%
1Y
−16.14%
YTD
−12.78%

Financials

Revenue, profit & margin
P/E ratio
18.7×
ADVENZYMES is 62% below the sector median of 48.7×
ADVENZYMES18.7×
Sector median48.7×
 Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Trend
Sales147158161158155146169167186185172203190
Expenses103107107102103104114122129124123140139
Operating Profit44515455514255465660496351
OPM %30%32%33%35%33%29%33%27%30%33%29%31%27%
Other Income7614-67108991020713
Interest1111111111111
Depreciation9999999101010101010
Profit before tax41485940494253435560586054
Tax %29%27%28%25%28%21%27%38%26%25%26%24%28%
Net Profit29354230353339274045434539
EPS in Rs2.583.083.742.533.052.943.372.373.573.873.803.843.31
Raw PDF

Earnings

Results dates & reactions
Next results
31 Oct '26rescheduled

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

No reaction history yet.
No quarterly filings ingested yet.

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
43.56%Promoter
Promoters43.56%0.31
FIIs26.64%0.06
DIIs1.89%2.88
Public27.90%2.62
Ownership trend

Peers

6 companies
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Anthem Bioscienc₹828.8078.6946,6890.24%120−11.67%418−22.58%30.37%
Advanced Enzyme₹263.5518.732,9512.03%39−7.11%190+2.09%13.96%
CCME Global₹33.55—1520.00%0−116.67%0—−2.92%
Vivo Bio Tech₹13.72—300.00%0−85.82%14+14.15%7.74%
Shree Ganesh Bio₹0.43—170.00%−1−272.73%1+3.62%1.31%
Genomic Valley₹48.10—150.00%0—0−100.00%1.02%
Median: 3 Co.₹263.5548.712,9510.24%39−11.67%190−10.24%13.96%

Filings

Annual reports15
Annual Report 2026Annual Report 2025Annual Report 2024Annual Report 2023Annual Report 2022Annual Report 2021Annual Report 2020Annual Report 2019Annual Report 2018Annual Report 2017Annual Report 2016Annual Report 2015Annual Report 2014Annual Report 2013Annual Report 2012
Concall transcripts100
TranscriptAug 2026PPTAug 2026RECAug 2026TranscriptMay 2026PPTMay 2026RECMar 2026TranscriptFeb 2026PPTFeb 2026RECFeb 2026TranscriptNov 2025PPTNov 2025PPTSep 2025TranscriptAug 2025PPTAug 2025TranscriptMay 2025PPTMay 2025TranscriptFeb 2025PPTFeb 2025TranscriptNov 2024PPTNov 2024RECNov 2024TranscriptAug 2024PPTAug 2024TranscriptMay 2024
Credit ratings6
Rating update 30 AprcrisilRating update 13 FebicraRating update 30 Jan 2025crisilRating update 28 Dec 2023crisilRating update 31 Oct 2022crisilRating update 18 Aug 2021crisil
Announcements5
Announcement under Regulation 30 (LODR)-Closure of Buy Back 30 Oct - Company closed ₹697 million buyback on Oct 30, 2026 after repurchasing 2,410,906 shares at ₹289.09 average.Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares 30 OctAnnouncement under Regulation 30 (LODR)-Daily Buy Back of equity shares 29 Oct - 29 Oct 2026 buyback report: 54,455 shares repurchased at ₹263.7616; cumulative buyback 24,10,906 shares.Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares 28 Oct - Daily buyback report: 64,583 shares bought on October 28, 2026 at ₹262.49 average price.Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares 27 Oct